Lack of sleep, already considered a public health epidemic, can also lead to errors in memory, finds a new study by researchers at Michigan State University and the University of California, Irvine.

Although HIV can now be effectively suppressed using anti-retroviral drugs, it still comes surging back the moment the flow of drugs is stopped. Latent reservoirs of HIV-infected cells, invisible to the body’s immune system and unreachable by pharmaceuticals, ensure that the infection will rebound after therapy is terminated.

Salk researchers discover a master gene responsible for sleep and wake cycles, offering hope for a drug that could help reset sleep.

Four undergraduate teams design creative new solutions to longstanding healthcare problems.

In an ecosystem within us, microbes evolved to sway food choices

As the Food and Drug Administration (FDA) mulls over whether to rein in the use of common antibacterial compounds that are causing growing concern among environmental health experts, a team of scientists led by Arizona State University Biodesign Institute researchers are now reporting that many pregnant women and their fetuses are being exposed to these substances.

A computer model study reveals – for the first time – details of an energy-creating process vital and unique to cancer cells. The research holds promise for new interventions and for personalizing cancer treatments based on individual needs.

UC San Francisco study suggests healthy diet, sleep and exercise can mitigate negative impacts of stress.

Companies combine expertise to produce cytomegalovirus vaccine candidates.

Henrik Dohlman, PhD, discovered why seemingly identical cells might react differently to the chemical signals inside our bodies and the drugs we use to battle diseases.

New OSU technology may help save some of the 200,000 lives a year lost due to the use of conterfeit anti-malarial drugs.

The Centers for Disease Control and Prevention (CDC) released a report on July 11 that reviews the early June incident that involved the unintentional exposure of personnel to potentially viable anthrax at the CDC’s Roybal Campus. The report identifies factors found to have contributed to the incident; and highlights actions taken by the agency to address these factors and prevent future incidents. Based on a review of all aspects of the June incident, CDC concluded that while it is not impossible that staff members were exposed to viable B. anthracis, it is extremely unlikely that this occurred. None of the staff who was potentially exposed has become ill with anthrax.